Home > Companies > United Medical Devices

United Medical Devices

playboycondoms.com

Playboy Condoms launched in 2010 and has seen the fastest growth in the condom segment out of any other brand. Since the launch, Playboy Condoms has secured distribution in over 80 countries around the world and our products are now on the shelves of major convenience stores and pharmacies in over 30 countries, with the number of retailers increasing by the quarter, with many more almost through local health requirements to receive goods. Since the launch of Playboy Condoms, we have doubled our world wide shipments of containers year over year.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

National Medtech & Biotech Summit 2024

Conference

2024 AAPS NATIONAL BIOTECHNOLOGY CONFERENCE

Conference

Related News

Business Insights

SATIO AND INSTITUT PASTEUR DE DAKAR FORM STRATEGIC PARTNERSHIP ON RESEARCH, DEVELOPMENT, MANUFACTURE, AND DISTRIBUTION

Satio, Inc and Institut Pasteur de Dakar | August 24, 2022

Satio, Inc., a privately held medical device company developing breakthrough, consumer-driven diagnostic and drug delivery solutions, announced a strategic partnership agreement with Institut Pasteur de Dakar. By combining SatioRxTM intradermal patches and Institut Pasteur de Dakar technologies, the partnership aims to accelerate clinical development of and access to vaccine patches for addressing epidemics, as well as diagnostic patches for blood sampling, genetic testing, and pa...

Business Insights, VIEWS AND ANALYSIS

MIRION TECHNOLOGIES TO DIVEST BIODEX PHYSICAL MEDICINE

Biodex Medical Systems | November 30, 2022

Mirion Technologies, Inc. announced that it has entered into a definitive agreement to sell the physical medicine assets of Biodex Medical Systems, Inc. to Salona Global Medical Device Corporation for $5 million in cash at closing and up to an additional $3 million in deferred cash payments. The deferred cash payments are contingent on the performance of the assets during the 12-month period following closing. The assets generated approximately $18 million in revenue with estimated gross margins...

Pharma Tech

VIVERA RECEIVES 3RD U.S. PATENT ALLOWANCE FOR ZICOH DRUG DELIVERY DEVICE

Vivera Pharmaceuticals, Inc. | May 26, 2022

Vivera is pleased to announce the allowance of its third U.S. patent for ZICOH™, the Company's high-tech, electronic dose-controlled portfolio of drug delivery devices. The patent allowance from the U.S. Patent and Trademark Office secures ZICOH's rights as a smart dosing system with automated delivery, measurement, and management for oral format medications, including pills, capsules, and tablets. ZICOH is an electronic dose-controlled delivery device and technology...

Pharma Tech

VALGENESIS AND PHARMENG TECHNOLOGY PARTNER TO MODERNIZE AND DIGITIZE VALIDATION AND COMPLIANCE FOR GLOBAL PHARMA, BIOTECH, MEDICAL DEVICE

PRNewswire | June 07, 2023

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and PharmEng Technology, a global ISO-certified consulting firm focused on life sciences, have partnered to provide a range of regulatory intelligence, GxP compliance, and digitized validation solutions for pharmaceutical, biotechnology, medical device, and nutraceutical companies across the globe. PharmEng Technology has staff all over the world serving companies of all sizes, prov...

Business Insights